Patients with gout at increased risk for cardiovascular disease and adverse event
Search results for: anakinra
Meet the Model Biologics Policy
At its February meeting, the ACR board of directors approved the Model Biologics Policy, which will be used when discussing guidelines and patients’ quality of treatment with health insurance companies.
Cochrane Launches Journal Club with RA Article
Overview of studies on biologic use kicks off monthly literature review feature
Decoding Autoinflammatory Syndromes
Understanding the genetic basis of errors of the immune system may provide new opportunities for therapy
Is B a Key to Autoimmune Therapy?: B Cell–targeted Therapies in Autoimmune Disease
A perspective on B cell–targeted therapies in autoimmune disease
Meet the HEP C Challenge
Keep a hepatitis C virus infection from hindering RA treatment
Nature’s Inflammation Experiment
Familial Mediterranean fever a frequently misdiagnosed autoinflammatory disease
My Michael Moore Moment
In which an angry letter finds its mark, to no avail
Pursue Remission
Disease remission should be the goal for all rheumatologists treating childhood arthritis
Difficult Gout
“Grandpapa’s Torments” was the Rodnan Commemorative Gout Print featured at the 2005 ACR/ARHP Annual Scientific Meeting.
- « Previous Page
- 1
- …
- 7
- 8
- 9